Correlation of Monoclonal and Polyclonal Somatostatin Receptor (SSTR) 5 Antibodies in Pancreatic Neuroendocrine Tumors
#657
Introduction: For a few years now, highly specific monoclonal antibodies have been available to characterize neuroendocrine tumors for somatostatin-receptor (SSTR) expression.
Aim(s): To evaluate the frequency of somatostatin-receptor 5 in pancreatic neuroendocrine tumors by using monoclonal and polyclonal antibodies.
Materials and methods: We analyzed 66 proven pancreatic neuroendocrine tumors immunohistochemically with monoclonal (clone UMB-4) and polyclonal SSTR 5-antibodies. Immunoreactive score (IRS) and DAKO-score Her2/neu were evaluated.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Peter L
Authors: Kaemmerer D, Lupp A, Peter L, Fischer E, Schulz S,
Keywords: somatostatin, pancreatic tumor, neuroendocrine tumor, monoclonal antibody, UMB-4,
To read the full abstract, please log into your ENETS Member account.